ISBT/SRI Transfusion Round-Up
Systematic Review Initiative (SRI) host the fully searchable libraries that are available free at the point of access to medical practitioners, policymakers and researchers worldwide, providing a comprehensive and up-to-date database of high-quality evidence in Transfusion Medicine.
From the ISBT side, this initiative is being led by Dr Allison Mo, a clinical and laboratory Haematologist from Melbourne, Australia, and we’ll welcome input from other ISBT members interested in taking part in the review process for future issues.
All references are drawn from the SRI Transfusion Evidence Library and, where relevant, Stem Cell Evidence Library.
Would you like to help with selecting and reviewing papers for future Transfusion Evidence Round-Ups?
We would like to invite interested ISBT members to apply to participate in the selection and review of papers for future Transfusion Evidence Round-Ups. Each Round-Up will be based on a different transfusion-related theme. No prior experience in doing evidence round-ups or systematic reviews is necessary, but experience with reviewing abstracts, manuscripts or similar would be helpful. Members will be supported in the process by the TEL and the ISBT.
Systematic Research Initiative
The Systematic Review Initiative (SRI) is a clinical research group established in 2001 by NHS Blood and Transplant (NHSBT) and funded by the UK Blood Services. The primary objective of the SRI is to “develop the evidence base for the practice of transfusion medicine”, by undertaking systematic reviews and other evidence-based medicine research projects in the transfusion field. @sritransfusion
Transfusion Evidence Library
Stem Cell Evidence
Stem Cell Evidence is a comprehensive collection of high quality research relevant to haematopoietic stem cell transplantation, updated monthly. The most important articles in the field are highlighted in the Stem Cell Evidence Alert which is a newsletter emailed to subscribers. Stem Cell Evidence aims to be a key resource worldwide for medical practitioners, clinical researchers and policy makers. It is also intended to be of value to those planning new clinical trials in the field. It is produced by the Systematic Review Initiative and funded by the UK Blood Services and Oxford Biomedical Research Centre.